Strategic Advantage for Life Science Innovators
The fast-paced pharmaceutical marketplace is rich with opportunity and demands a strategy based upon innovation of products, services, and refined, targeted, business models to keep pace with changing market conditions.
Haig Barrett provides the strategic foundation to enable companies working across the life sciences value chain to stay ahead of the demanding pace of the market. We work in a ‘co-creative’ process with our client’s vision in which critical planning, budget, and project targets are coordinated seamlessly. Integrated action produces results.
Make better, more informed decisions with strategic guidance for profitability and growth.
HB Supports Codexis Game-changing Innovation
Codexis is a world leader in providing unique, state-of-the-art protein engineering and enzyme optimization services. Their technology makes it possible to engineer new proteins and enzymes that are the foundation of new drugs that can be developed and manufactured efficiently.
Codexis CodeEvolver Technology
Codexis proprietary CodeEvolver® protein engineering technology platform enables the rapid development of highly optimized proteins, custom-designed for our clients’ specific therapeutic or process-relevant applications.
HB has provided support in communicating the complex narrative around the layers of innovation that make up the CodeEvolver technology. The system makes highly creative use of Artificial Intelligence technology to sift protein candidates and optimize the most viable candidates, saving time and money, and shaping a successful outcome in many subtle ways.
Codexis technology has brought change and opportunity to pharmaceutical development process, and HB is supporting Codexis in communicating this transformation at all levels— from strategic business insight, to pharmaceutical products and services, to deep technical pharmaceutical chemistry. The story of this transformative innovation operates at all levels, and HB is seeking to provide Codexis advantage and market focus at every point.
“Building Blocks of New Pharma”
Navigating the ever changing terrain of bio tech, pharmaceutical, and medtech…
More demanding healthcare, regulatory, and consumer driven agendas are changing the environment for Life Science and Pharmaceutical companies. It has become increasingly harder to meet the needs of these new demands.
As a result a need for innovative, cost effective medicine continues to rise as it is imperative for companies to improve R&D productivity, increase the efficiency of its operations, and rationalize spending on sales and marketing to enhance financial performance.
The goal of the Bio Tech Summit is to help companies understand, navigate, and stay ahead of trends.
Currently the Top 5 Trends in BioTech are:
- Enzymes, stem cell and gene therapies evolve into futuristic treatments
- New drug technology moves ahead with a host of new BioTech
- BioTech goes global as Asia gets connected to industry leaders in the U.S. and Europe
- The BioTech Sector rides the Mergers & Acquisition wave
- Customer driving Pharma – Customer experience, knowledge and demand for personalized medicine is increasing
Staying Ahead of the Curve
The life sciences marketplace is fast paced, and driven by innovation. Leading companies in Pharma and Bioscience need creative insight and strategic support to build successful businesses based on their innovative technologies.
At Haig Barrett, we are committed to being future forward and staying ahead of market trends and technology for our committed clients. It is in this vein and through our Think Tank relationships that we have found a very valuable partnership in the Life Sciences Industry. We are very excited to announce that Los Angeles based Haig Barrett, Inc. Management Consultants and That’s Nice LLC a New York-based global marketing agency have created Nice Consulting.
Nice Consulting brings strategic and specialized consulting tailored to the needs of life science companies, for the first time a global science marketing agency and a world-class consulting firm working in a single, integrated operation. Nice Consulting provides the knowledge, experiences and services to bring a new level of value to the marketplace.
Engineering Success: Codexis President & CEO Shares Lessons About Corporate Change Management – Given the dynamics of today’s business climate, it might come as no surprise that change management is a topic that emerges constantly as the Haig Barrett team and I interact with executives and executive leadership teams. After years leading the Haig Barrett team to help our clients thrive during periods of great change, I sought to learn even more. There seemed no better person to talk to than John Nicols, president and CEO of Codexis. Read More
Behind the Scenes of International Pharmaceutical Business Success: A Conversation with Horst Wallrabe – After years leading the Haig Barrett team to help US companies thrive in international markets or global companies prosper in the United States, it seemed a good time to start sharing some thoughts on the topic. To my mind, the best way to explore this subject is to talk with executives who have been there. There seemed no better place to start than with Horst Wallrabe, formerly the President of the Pharmaceutical Division of Bayer. Read More
Trend: Big Data and Artificial Intelligence in Healthcare – Big data, artificial intelligence, machine learning…these topics seem to be everywhere in both the business and consumer news media. But these terms can be confusing, misused, and misunderstood. Regardless, the use of big data to drive artificial intelligence technologies is revolutionizing the healthcare sector, including pharmaceutical and therapeutics developers and medical service providers. Read More
Perspectives On Drug Product Pricing Strategy and Practice – Drug pricing remains pharma’s most contentious issue. Under tremendous pressure, the industry continues to evolve pricing strategy to satisfy intensive regulation, social/political scrutiny and competitive market forces — how other industries face the challenge of pricing may offer fresh insight to fuel an effective strategy. Getting pricing “right” is a tricky balancing act, but one that offers tremendous value for all. – Read More
Perspective On Product Pricing Strategy and Practice – Drug pricing remains pharma’s most contentious issue. Under tremendous pressure, the industry continues to evolve pricing strategy to satisfy intensive regulation, social/political scrutiny and competitive market forces — how other industries face the challenge of pricing may offer fresh insight to fuel an effective strategy. Getting pricing “right” is a tricky balancing act, but one that offers tremendous value for all. Read More
Sustainable Strategies for CDMO Service Growth – Acquisition has become a favorite tactic by contract pharma’s most prominent players, but there’s more than one path to sustained growth, especially for those seeking the scale, global presence and technical acumen the bio/pharmaceutical industry is demanding. This article reveals other sustainable strategies for CDMO growth. Read More
M&A: Protecting The Core And Maximizing Value – With a number of mergers and acquisitions taking place in the CRO and CMO/CDMO space, this article highlights several areas driving the success of those new organizations, including: acquisition target criteria, fit with acquiring entity, building management consensus and performance expectations, onboarding new sites and teams, inclusive employee communications and projecting a new brand internally and externally. Read More
Customer Experience: Key To Growth In The Outsourced Service Industry – Building a client relationship that results in repeat orders and leads to a long-term partner- ship between the CMO and Sponsor requires the “customer experience” to meet or exceed client expectations. Customer experience is not the same as customer satisfaction, which is of- ten measured. A CMO’s ability to respond effectively to a client’s needs and demands shapes the customer experience. This article looks at the impact of communications, adaptability, and ways to improve the customer experience. Read More
Cultural Competence In Pharma: Multicultural Marketing Is A Competitive Advantage – The healthcare industry is going through a global transformation with the advent of new technologies and the ability to reach consumers across country boundaries. Because of this, cultural value based strategy and messaging is more important than ever before. Read More
PRESS RELEASE: HAIG BARRETT AND THAT’S NICE AGENCY ANNOUNCE THE FORMATION OF NICE CONSULTING at the CPhI Worldwide in Madrid Spain on October 12th, 2015
HAIG BARRETT JOINS THAT’S NICE AGENCY FOR THE BIO CONVENTION The BIO convention is known as the Global Event for Biotechnology.
Over 25 top pharmaceutical and 300 academic institutions were in attendance at this event where the convention highlighted how leading biopharma firms are mobilizing to take on tough diseases.